Quanterix wins NMPA approvals for SIMOA instruments, biomarker kits in China
Quanterix said China’s NMPA approved its HD-X and SR-X instruments and four SIMOA neurology biomarker kits via partner Innovita.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Quanterix said China’s NMPA approved its HD-X and SR-X instruments and four SIMOA neurology biomarker kits via partner Innovita.